From the Food and Drug Administration.
Nightingale
S L
SL
D000890:Anti-Infective Agents / Q000009:adverse effects; D024841:Fluoroquinolones; D006801:Humans; D009287:Naphthyridines / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin